creating a
healthier future

DONATE NOW SUPPORT SCIENCE

News

26.03.27

i3S researcher wins yESAO Research Exchange Award

Rosmarie Schoefbeck will undertake a scientific exchange at a German university hospital to study the blood compatibility of clinical-use biomaterials.

26.03.26

Students recognized for work on Malaria and Leishmaniasis

Filipa Neves and Ricardo Monteiro received awards at the “Parasitology in Portugal” 2026 Symposium, which brought together the parasitology scientific community in Lisbon.

26.03.26

i3S researcher wins grant to study at Oxford

Joana Machado will learn the cutting-edge POINT-Seq methodology and boost her doctorate with a two-month stay at the University of Oxford.

26.03.26

Bruno Sarmento among the most influential specialists in Biomedical Engineering

The i3S researcher has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).

26.03.26

PhD student receives EMBO fellowship to investigate colorectal cancer in the UK

Alexandre Coelho, a PhD student in Molecular and Cellular Biology at U.Porto, will study chemotherapy resistance for three months at the University of Cambridge.

26.03.26

i3S 10th Anniversary: turning mirrors into windows

This year, i3S celebrates 10 years of existence. However, the knowledge it creates is always in motion. It is a window that connects the past and the future.

26.03.19

Young i3S researchers awarded “la Caixa” doctoral fellowships

Award‑winning INPhINIT Retaining fellowships support research projects on tissue regeneration, ageing, and gene regulation.

26.03.17

Mónica Sousa wins the University of Porto’s Award for Excellence in Scientific Research

The i3S researcher was one of five selected from a field of 29 candidates.

26.03.13

Gilead GENESIS honours i3S researcher

Delfim Duarte has received funding to study new immunotherapy strategies for aggressive B-cell lymphomas, as part of a project involving i3S and IPO Porto.

Subscribe to our newsletter and keep up to date with our latest achievements.

Newsletter Subscription

Contacts
Status & Reports
Privacy Policy
Cookie Policy
Terms & Conditions
Whistleblower Channel